NEW YORK–(BUSINESS WIRE)–BTIG announced today that Ophthalmology Day at BTIG will take place on Tuesday, November 29, 2022. The virtual, one-day event will include thematic panel discussions, one-on-one meetings and company presentations. The event w…
Author: Business Wire
Xeris Biopharma Announces Research Collaboration and Option Agreement With Horizon Therapeutics plc for XeriJect™ Formulation of Teprotumumab
CHICAGO–(BUSINESS WIRE)– #GvokeHypoPen–Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products across a range of therapies,…
LENSAR to Present at Two Upcoming Investor Conferences
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (NASDAQ: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced Nick Curtis, Chief Exe…
OcuTerra to Participate in Upcoming Investor Conferences
BOSTON–(BUSINESS WIRE)–OcuTerra announces participation in upcoming BTIG and Cantor Fitzgerald investor conferences.
EnChroma unterstützt farbenblinde Studenten an der RWTH Aachen
AACHEN, Deutschland & BERKELEY, Kalifornien, USA–(BUSINESS WIRE)– #enchroma–Wie VORSCHUB, die Vertretung Studierender mit Behinderung und chronischer Erkrankung an der technischen Hochschule RWTH Aachen heute bekannt gab, können sich farbenblinde St…
EnChroma Supports Colourblind Students at RWTH Aachen University
AACHEN, Germany & BERKELEY, Calif.–(BUSINESS WIRE)– #enchroma–VORSCHUB at RWTH Aachen University today announced that colourblind students and staff will now be able to borrow EnChroma colourblind glasses on campus to help them overcome the obstacle…
Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
GENEVA–(BUSINESS WIRE)–Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical Business
Innovations and Growth Opportunities in Novel Diagnostics and Monitoring Solutions, Robotic Surgical Systems, AI Enabled Devices – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Innovations and Growth Opportunities in Novel Diagnostics and Monitoring Solutions, Robotic Surgical Systems, AI Enabled Devices” report has been added to ResearchAndMarkets.com’s offering. The latest issue of Advanced Med…
Align Business Advisory Services Adds Dr. Jeffrey Baumann to Advisory Board
WINTER PARK, Fla.–(BUSINESS WIRE)–Align Business Advisory Services, a top-rated mergers & acquisitions (M&A) advisory firm for lower-middle market businesses, announces the addition of Dr. Jeffrey Baumann to its Advisory Board. Dr. Baumann is…
Global Eyewear Market Intelligence Report to 2027 – Players Include Alcon Vision, Bausch Health Companies, Carl Zeiss and Charmant – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Eyewear Market Intelligence Report – Global Forecast to 2027” report has been added to ResearchAndMarkets.com’s offering. The Global Eyewear Market is projected to reach USD 310.34 billion by 2027 from USD 155.39 billion i…
Worldwide Single Use Ophthalmic Surgical Devices Industry to 2027 – Material Improvements Used in Single-Use Surgical Devices is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Single Use Ophthalmic Surgical Devices Market Research Report by Product, Application, End-user, Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering….
Global Optogenetics Market to Expand by $676.56 Million During 2022-2026 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Optogenetics Market 2022-2026” report has been added to ResearchAndMarkets.com’s offering. The optogenetics market is poised to grow by $ 676.56 mn during 2022-2026, progressing at a CAGR of 16.39% during the foreca…
InSitu Biologics Shares Latest Investigational Work at ASRA Meeting
OAKDALE, Minn.–(BUSINESS WIRE)–InSitu Biologics, Inc. will share the latest investigational work on its multi-phase drug delivery matrix at the upcoming 21st Annual Pain Medicine Meeting of the American Society of Regional Anesthesia on November 18th…
Heru Wins Prestigious CES Innovation Award for 2nd Consecutive Year with Expanded, Multimodal Platform
MIAMI–(BUSINESS WIRE)–Today, Heru Inc. announced it has been named an honoree in the Virtual & Augmented Reality category of the CES Innovation Awards for a second consecutive year. The company is being recognized after a year of rapid innovation…
STAAR Surgical Opens EVO Experience Center in United States
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced the opening of the first company-operated EVO Experience Center. The center i…
Azura Ophthalmics Announces Positive Results from Phase 2b Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction
TEL AVIV, Israel & MELBOURNE, Australia–(BUSINESS WIRE)–Azura Ophthalmics Announces Positive Phase 2b Results from Clinical Trial of AZR-MD-001 in Meibomian Gland Dysfunction
NovaBay Pharmaceuticals Chief Product Officer Dr. Audrey Kunin Returns to the QVC® Network With DERMAdoctor’s Eczema Balm
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a company developing and commercializing high-quality eyecare, skincare and wound care products, announces that Chief Product Officer Audrey Kunin, MD will return…
Global Ophthalmic Ultrasound Systems Market Report 2022: Rising Burden of Eye Diseases Fuels Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmic Ultrasound Systems Market – Forecast 2021 to 2026” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmic ultrasound systems market is projected to grow at a CAGR of 7.93% durin…
Radius XR™ Named as the CES 2023 Innovation Award Honoree for Wearable Device That Combines Therapy and Diagnostic Capabilities
PLEASANTON, Calif.–(BUSINESS WIRE)– #Ophthalmology–Today at the CES Unveiled New York event, Radius XR™, a new fashion-forward wearable healthcare technology brand, was named a CES® 2023 Innovation Awards Honoree in both the Digital Health and Virtu…
Horizon Therapeutics plc Announces Completion of Enrollment of Phase 3 Clinical Trial (OPTIC-J) in Japan Evaluating TEPEZZA® (teprotumumab-trbw) for the Treatment of Active Thyroid Eye Disease (TED)
DUBLIN–(BUSINESS WIRE)–Horizon announced that enrollment of its Phase 3 clinical trial (OPTIC-J) in Japan evaluating TEPEZZA for the treatment of active TED is complete.